UNSPSC 85252843: Diagnosis of acute myeloblastic leukaemia or aml

This classification denotes the group of activities that yields a diagnosis of Acute myeloblastic leukaemia or AML. Acute myeloblastic leukaemia or AML is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C92. 0

UNSPSC 85252843 Diagnosis of acute myeloblastic leukaemia or AML is a Commodity code with no recent state and local contract opportunities showing procurement activity directly aligned with its nominal scope. The three most recent opportunities posted under or near this code—San Mateo Medical Center's Diagnostic Imaging PACS system procurement, Birdville Independent School District's special education contracted services, and Santa Clara County Health System's temporary health professional staffing—involve clinical diagnostic and staffing infrastructure rather than AML-specific diagnostic services or related pharmaceutical products. The mismatch suggests either tagging misalignment in the source data or minimal recent state and local purchasing activity under this particular commodity classification.

Without representative opportunities in the source block that directly address AML diagnostic procurement, diagnosticians, laboratory reagents, or related services, no geographic concentration, issuing-body pattern, or market characterization can be drawn. Business development professionals evaluating this code should verify whether the UNSPSC classification is actively used by state and local health systems and clinical procurement offices for AML diagnostic services, reagents, or related testing—or whether opportunities in this space are tagged under broader diagnostic or laboratory service codes and not surfaced under this commodity-level classification.